Carbinoxamine Maleate
NDC 44523-825, Carbinoxamine Maleate, tablet, from Biocomp Pharma, Inc..
- Product NDC
- 44523-825
- Status
- Listed
- Labeler
- Biocomp Pharma, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090756
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/44523-825 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARBINOXAMINE MALEATE4 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 44523-825-01 | 44523082501 | 1 BOTTLE in 1 CARTON (44523-825-01) / 100 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/14266e97-674b-b6a9-37a2-a955f0a01c4fNADAC price for package 44523082501
GET /v1/drugs/nadac/44523082501
Use it
Look up 44523-825 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/44523-825 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 44523-825. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.